SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-023285
Filing Date
2016-08-08
Accepted
2016-08-08 16:16:32
Documents
63
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q akba-10q_20160630.htm 10-Q 1693420
2 EX-31.1 akba-ex31_7.htm EX-31 17263
3 EX-31.2 akba-ex31_8.htm EX-31 17279
4 EX-32.1 akba-ex32_6.htm EX-32 11871
5 EX-99.1 akba-ex99_9.htm EX-99 111483
6 GRAPHIC gnrzh042hwyy000001.jpg GRAPHIC 2066
  Complete submission text file 0001564590-16-023285.txt   6893767

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT akba-20160630.xml EX-101.INS 1614556
8 XBRL TAXONOMY EXTENSION SCHEMA akba-20160630.xsd EX-101.SCH 44598
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE akba-20160630_cal.xml EX-101.CAL 47403
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE akba-20160630_def.xml EX-101.DEF 152942
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE akba-20160630_lab.xml EX-101.LAB 338594
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE akba-20160630_pre.xml EX-101.PRE 272435
Mailing Address 245 FIRST STREET SUITE 1100 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1100 CAMBRIDGE MA 02142 617-871-2098
Akebia Therapeutics, Inc. (Filer) CIK: 0001517022 (see all company filings)

IRS No.: 208756903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36352 | Film No.: 161814349
SIC: 2834 Pharmaceutical Preparations